Literature DB >> 8562539

Acanthamoeba keratitis: risk factors and outcome.

C D Illingworth1, S D Cook, C H Karabatsas, D L Easty.   

Abstract

AIMS/
BACKGROUND: This study was initiated to investigate risk factors for and outcome of Acanthamoeba keratitis.
METHODS: Results of treatment were studied in 22 patients (23 eyes) presenting to Bristol Eye Hospital between 1985 and February 1995. Details related to the use and disinfection of contact lenses were also obtained. An additional two patients who were seen at Bristol but mainly treated elsewhere were surveyed for contact lens related information only.
RESULTS: The incidence of Acanthamoeba keratitis rose substantially in the 1990s: three patients presented before 1990, while the remaining 21 presented between January 1990 and February 1995. Eleven patients have presented since january 1994. All of the patients in this series were contact lens wearers, 16 (67%) using daily wear disposable contact lenses. Contact lens disinfection data were available in 22 patients of whom 11 (50%) were using chlorine disinfectant. Other types of disinfection were much less common. Four patients (18%) had not used any disinfectant. During the course of the series the average diagnostic delay has fallen markedly, although in 77% of patients a diagnosis of a viral keratitis, most commonly herpes simplex, was made on first presentation. All but three of the series were treated with a combination of polyhexamethylene biguanide and propamidine isethionate. Penetrating keratoplasty was performed in 9/23 eyes (39%); in all of these eyes diagnosis was delayed for at least 6 weeks. All but one of the eyes in the series achieved a visual acuity of 6/9 or better after treatment, and 18 eyes (78%) saw 6/6 or better.
CONCLUSIONS: Most patients with Acanthamoeba keratitis can now expect a good visual result and cure by medical therapy alone is favoured by early diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562539      PMCID: PMC505344          DOI: 10.1136/bjo.79.12.1078

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Clinical signs and medical therapy of early Acanthamoeba keratitis.

Authors:  T D Lindquist; N A Sher; D J Doughman
Journal:  Arch Ophthalmol       Date:  1988-01

2.  Contamination of contact lens storage cases by Acanthamoeba and bacteria.

Authors:  D F Larkin; S Kilvington; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

3.  Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers.

Authors:  M B Moore; J P McCulley; C Newton; L M Cobo; G N Foulks; D M O'Day; K J Johns; W T Driebe; L A Wilson; R J Epstein
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

4.  Isolation, identification, and biological characterization of Acanthamoeba polyphaga from a human eye.

Authors:  G S Visvesvara; D B Jones; N M Robinson
Journal:  Am J Trop Med Hyg       Date:  1975-09       Impact factor: 2.345

5.  Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis.

Authors:  M B Moore; J P McCulley; H E Kaufman; J B Robin
Journal:  Ophthalmology       Date:  1986-10       Impact factor: 12.079

6.  The epidemiology of Acanthamoeba keratitis in the United States.

Authors:  J K Stehr-Green; T M Bailey; G S Visvesvara
Journal:  Am J Ophthalmol       Date:  1989-04-15       Impact factor: 5.258

7.  Acanthamoeba keratitis in soft contact lens wearers. A case-control study.

Authors:  J K Stehr-Green; T M Bailey; F H Brandt; J H Carr; W W Bond; G S Visvesvara
Journal:  JAMA       Date:  1987-07-03       Impact factor: 56.272

8.  Laboratory investigation of Acanthamoeba keratitis.

Authors:  S Kilvington; D F Larkin; D G White; J R Beeching
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 9.  Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease.

Authors:  G A Stern; M Buttross
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

10.  Herpes simplex masquerade syndrome: acanthamoeba keratitis.

Authors:  K J Johns; D M O'Day; W S Head; R J Neff; J H Elliott
Journal:  Curr Eye Res       Date:  1987-01       Impact factor: 2.424

View more
  28 in total

1.  Microbiological cure times in acanthamoeba keratitis.

Authors:  C E Oldenburg; J D Keenan; V Cevallos; M F Chan; N R Acharya; B D Gaynor; S D McLeod; E J Esterberg; T C Porco; T M Lietman
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

2.  [The German Acanthamoeba keratitis register: Initial results of a multicenter study].

Authors:  L Daas; N Szentmáry; T Eppig; A Langenbucher; A Hasenfus; M Roth; M Saeger; B Nölle; B Lippmann; D Böhringer; T Reinhard; C Kelbsch; E Messmer; U Pleyer; S Roters; A Zhivov; K Engelmann; J Schrecker; L Zumhagen; H Thieme; R Darawsha; T Meyer-Ter-Vehn; B Dick; I Görsch; M Hermel; M Kohlhaas; B Seitz
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

3.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.

Authors:  Jeena Mascarenhas; Prajna Lalitha; N Venkatesh Prajna; Muthiah Srinivasan; Manoranjan Das; Sean S D'Silva; Catherine E Oldenburg; Durga S Borkar; Elizabeth J Esterberg; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Ophthalmol       Date:  2013-11-05       Impact factor: 5.258

4.  Acanthamoeba keratitis: risk factors and outcome.

Authors:  J Hay; D V Seal
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

5.  Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group.

Authors:  C F Radford; O J Lehmann; J K Dart
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

6.  Tigecycline inhibits proliferation of Acanthamoeba castellanii.

Authors:  Bijay Kumar Jha; Incheol Seo; Hyun-Hee Kong; Seong-Il Suh; Min-Ho Suh; Won-Ki Baek
Journal:  Parasitol Res       Date:  2015-01-07       Impact factor: 2.289

7.  Visual outcome in Japanese patients with Acanthamoeba keratitis.

Authors:  K Yamazoe; Y Yamamoto; S Shimazaki-Den; J Shimazaki
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

Review 8.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

9.  Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Anders Magnuson; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-19       Impact factor: 3.117

10.  In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.

Authors:  Anjan Debnath; Josefino B Tunac; Angélica Silva-Olivares; Silvia Galindo-Gómez; Mineko Shibayama; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.